Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Waters

Showing results (151-160 of 198) with videos related to

Pageof 20
Sort By:
Multiple Sclerosis and Related Disorders|June 5, 2020
Bone health in neuromyelitis optica: Bone mineral density and fracturesYoung Nam Kwon, Sun Young Im, Yong-Shik Park, et al.
Multiple Sclerosis and Related Disorders|January 25, 2020
Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseasesYeseul Kim, Jae-Won Hyun, Mark R Woodhall, et al.
Acta Neuropathologica Communications|October 29, 2022
Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapyMiriam L Fichtner, Kenneth B Hoehn, Easton E Ford, et al.
Annals of Laboratory Medicine|September 4, 2023
Clinical Usefulness of a Cell-based Assay for Detecting Myelin Oligodendrocyte Glycoprotein Antibodies in Central Nervous System Inflammatory DisordersJin Myoung Seok, Patrick Waters, Mi Young Jeon, et al.
Brain : a Journal of Neurology|December 23, 2017
The importance of early immunotherapy in patients with faciobrachial dystonic seizuresJulia Thompson, Mian Bi, Andrew G Murchison, et al.
Acta Neuropathologica Communications|December 7, 2017
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody diseaseMaciej Jurynczyk, Fay Probert, Tianrong Yeo, et al.
Brain : a Journal of Neurology|June 22, 2014
Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomesAlexander Carvajal-González, M Isabel Leite, Patrick Waters, et al.
The Lancet. Psychiatry|September 20, 2024
Clinical symptoms and psychosocial functioning in patients with schizophrenia spectrum disorders testing seropositive for anti-NMDAR antibodies: a case-control comparison with patients testing negativeJurjen J Luykx, Robbert Visscher, Inge Winter-van Rossum, et al.
Brain : a Journal of Neurology|February 4, 2026
Optimal strategies for treatment discontinuation in MOG antibody-associated diseaseWei Z Yeh, Anna Francis, Sarah Cooper, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2024
Ultrahigh frequencies of peripherally matured LGI1- and CASPR2-reactive B cells characterize the cerebrospinal fluid in autoimmune encephalitisJakob Theorell, Ruby Harrison, Robyn Williams, et al.
Pageof 20

Showing results (151-160 of 198) with videos related to

Sort By:
Pageof 20
Multiple Sclerosis and Related Disorders|June 5, 2020
Bone health in neuromyelitis optica: Bone mineral density and fracturesYoung Nam Kwon, Sun Young Im, Yong-Shik Park, et al.
Multiple Sclerosis and Related Disorders|January 25, 2020
Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseasesYeseul Kim, Jae-Won Hyun, Mark R Woodhall, et al.
Acta Neuropathologica Communications|October 29, 2022
Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapyMiriam L Fichtner, Kenneth B Hoehn, Easton E Ford, et al.
Annals of Laboratory Medicine|September 4, 2023
Clinical Usefulness of a Cell-based Assay for Detecting Myelin Oligodendrocyte Glycoprotein Antibodies in Central Nervous System Inflammatory DisordersJin Myoung Seok, Patrick Waters, Mi Young Jeon, et al.
Brain : a Journal of Neurology|December 23, 2017
The importance of early immunotherapy in patients with faciobrachial dystonic seizuresJulia Thompson, Mian Bi, Andrew G Murchison, et al.
Acta Neuropathologica Communications|December 7, 2017
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody diseaseMaciej Jurynczyk, Fay Probert, Tianrong Yeo, et al.
Brain : a Journal of Neurology|June 22, 2014
Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomesAlexander Carvajal-González, M Isabel Leite, Patrick Waters, et al.
The Lancet. Psychiatry|September 20, 2024
Clinical symptoms and psychosocial functioning in patients with schizophrenia spectrum disorders testing seropositive for anti-NMDAR antibodies: a case-control comparison with patients testing negativeJurjen J Luykx, Robbert Visscher, Inge Winter-van Rossum, et al.
Brain : a Journal of Neurology|February 4, 2026
Optimal strategies for treatment discontinuation in MOG antibody-associated diseaseWei Z Yeh, Anna Francis, Sarah Cooper, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2024
Ultrahigh frequencies of peripherally matured LGI1- and CASPR2-reactive B cells characterize the cerebrospinal fluid in autoimmune encephalitisJakob Theorell, Ruby Harrison, Robyn Williams, et al.
Pageof 20